Anavex Life Sciences (AVXL) Notes Payables (2009 - 2016)
Anavex Life Sciences' Notes Payables came in at $92,516 for fiscal Q3 2015 (quarter ended Jun 30, 2015), down 53.9% from $200,835 a year earlier but up 2.3% from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Notes Payables (2009 - 2016) Analysis & Trends
At the end of FY2014 (ended Sep 30, 2014), Anavex Life Sciences' Notes Payables was $192,065, down 8.9% from FY2013.
- Notes Payables has declined in each of the last three fiscal years, with a three-year compound annual growth rate of -39.5% (FY2011 to FY2014).
- Going back by fiscal year, Notes Payables was $210,863 in FY2013 (-29.5%), $299,000 in FY2012 (-65.5%) and $867,919 in FY2011.
- The five-year range for quarterly Notes Payables is $49,000 (fiscal Q3 2012) to $1.2 million (fiscal Q2 2012).
- Year-over-year, Notes Payables has declined for eight consecutive quarters, with an average decline of 51.4% over the last eight quarters.
- Over the past five years, the year-over-year decline in Notes Payables ranged from 8.9% (fiscal Q4 2014) to 74.6% (fiscal Q2 2014).
- Business Quant data shows AVXL's Notes Payables at $90,412 (Q2 2015), $98,312 (Q1 2015) and $192,065 (Q4 2014) in the three fiscal quarters before Q3 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Anavex Life Sciences | 104.75 Mn | -375.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 87,887.00 |
| Mar 31, 2016 | 88,145.00 |
| Dec 31, 2015 | 82,410.00 |
| Sep 30, 2015 | 85,238.00 |
| Jun 30, 2015 | 92,516.00 |
| Mar 31, 2015 | 90,412.00 |
| Dec 31, 2014 | 98,312.00 |
| Sep 30, 2014 | 192,065.00 |
| Jun 30, 2014 | 200,835.00 |
| Mar 31, 2014 | 193,720.00 |
| Dec 31, 2013 | 200,364.00 |
| Sep 30, 2013 | 210,863.00 |
| Jun 30, 2013 | 757,600.00 |
| Mar 31, 2013 | 761,292.00 |
| Dec 31, 2012 | 599,000.00 |
| Sep 30, 2012 | 299,000.00 |
| Jun 30, 2012 | 49,000.00 |
| Mar 31, 2012 | 1.20 Mn |
| Dec 31, 2011 | 1.16 Mn |
| Sep 30, 2011 | 867,919.00 |
API Access
Anavex Life Sciences Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();